Czechia vs Latvia: Share of E. coli infections resistant to cephalosporins
Czechia
14.4%
in 2022
Latvia
16.2%
in 2022
Czechia rank
35th
Latvia rank
34th
Share of E. coli infections resistant to cephalosporins over time
- Czechia
- Latvia
How they compare
Latvia currently reports 16.2% against 14.4% in Czechia, a difference of 1.8%.
That makes Latvia's figure about 1.1 times Czechia's.
Across all 6 years both countries report, Latvia has been ahead every year.
Czechia ranks 35th and Latvia ranks 34th of 46 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 14.9% | 18.8% | 3.9% | Latvia |
| 2020s | 14.0% | 22.8% | 8.9% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Czechia or Latvia?
- Latvia, at 16.2% against 14.4% in Czechia as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Czechia and Latvia?
- 1.8%, with Latvia ahead.
- How many years of comparable data are there for Czechia and Latvia?
- 6 years are reported by both, from 2017 to 2022.
- How do Czechia and Latvia rank globally for share of e. coli infections resistant to cephalosporins?
- Czechia ranks 35th and Latvia ranks 34th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).